tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Gordon, 31 are a BUY (43.06%), 40 are a HOLD (55.56%), 1 are a SELL (1.39%).
Analyst James Gordon, currently employed at BARCLAYS, carries an average stock price target met ratio of 56.21% that have a potential upside of 26.9% achieved within 209 days.
James Gordon’s has documented 130 price targets and ratings displayed on 13 stocks. The coverage is on Healthcare, Financial Services, Basic Materials, Consumer Defensive, Technology sectors.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 06-Jan-2026.
Analyst best performing recommendations are on MOR (MORPHOSYS AG ADR).
The best stock recommendation documented was for MOR (MORPHOSYS AG ADR) at 12/5/2023. The price target of $8.5 was fulfilled within 6 days with a profit of $0.92 (12.14%) receiving and performance score of 20.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Oct-2022
$74
$9.89 (15.43%)
$82
Hold Since 13-Oct-2025
$70
$5.89 (9.19%)
$78
7 days ago
(07-Oct-2026)
12/15 (80%)
$7 (11.11%)
575
Buy Since 08-Apr-2022
$98
$33.89 (52.86%)
$98
29 days ago
(15-Sep-2026)
14/32 (43.75%)
$30.24 (44.63%)
418
Buy Since 15-Apr-2019
$85
$20.89 (32.58%)
$80
2 months 2 days ago
(12-Aug-2026)
10/21 (47.62%)
$11.42 (15.52%)
389
Hold Since 12-Aug-2026
$78.4
$14.29 (22.29%)
$77.53
2 months 2 days ago
(12-Aug-2026)
3/4 (75%)
$4.82 (6.55%)
99
What Year was the first public recommendation made by James Gordon?
